Clinical significance of tri-nucleotide repeats in Fragile X testing: A clarification of American College of Medical Genetics guidelines-Reference-Cited by-同舟云学术

Clinical significance of tri-nucleotide repeats in Fragile X testing: A clarification of American College of Medical Genetics guidelines

Published:2008-11 Issue:11 Volume:10 Page:845-847
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Kronquist Kathryn E.,Sherman Stephanie L.,Spector Elaine B.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference10 articles.

1. Spector EB, Kronquist KE. Fragile X: technical standards and guidelines. ACMG standards and guidelines for clinical genetics laboratories 2005. Available at: www.acmg.net.

2. ACOG committee opinion No. 338: Screening for Fragile X syndrome. Obstet Gynecol 2006; 107: 1483–1485.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of robustness in gene regulatory networks involved in neural development;Frontiers in Molecular Neuroscience;2023-02-06

2. Ovarian Reserve Disorders, Can We Prevent Them? A Review;International Journal of Molecular Sciences;2022-12-06

3. Evidence for a fragile X messenger ribonucleoprotein 1 ( FMR1 ) mRNA gain‐of‐function toxicity mechanism contributing to the pathogenesis of fragile X‐associated premature ovarian insufficiency;The FASEB Journal;2022-10-17

4. FMR1 allele frequencies in 51,000 newborns: a large-scale population study in China;World Journal of Pediatrics;2021-11-05

5. The molecular mechanisms that underlie fragile X-associated premature ovarian insufficiency: is it RNA or protein based?;Molecular Human Reproduction;2020-08-10